Literature DB >> 12370094

Low dose of resveratrol enhanced immune response of mice.

Yong-Hong Feng1, Wen-Liang Zhou, Qing-Li Wu, Xiao-Yu Li, Wei-Min Zhao, Jian-Ping Zou.   

Abstract

AIM: To study the immune modulating effect of low dose of resveratrol.
METHODS: Concanavalin A (ConA) and Staphylococcus aureus Cowan (Sac) were used to induce the activation of T lymphocyte and antigen presenting cell and cytokine production. [3H]-Thymidine incorporation was used to evaluate the proliferation of lymphocyte. Cytokine production was detected by ELISA method. Dinitrofluorobenzene (DNFB) was used to induce mice delayed type hypersensitivity (DTH, delayed hypersensitivity) response and ear swelling was used as an evaluating indicator. Changes of lymphocyte subtypes were detected by flow cytometry.
RESULTS: Resveratrol (0.75-6 micromol/L) concentration-dependently promoted lymphocyte proliferation and IL-2 production induced by ConA. Sac induced IL-12 and IFN-gamma (interferon type II) production were also concentration-dependently enhanced by resveratrol, while IL-10 production was inhibited. Resveratrol (4 mg/kg, ig) promoted DTH response of mouse, which was suppressed by ethanol (16 %, w/v) consumption. Resveratrol treatment had no significant influence on lymphocyte subtypes in mice, however it could reverse the suppressive effect of ethanol both on macrophage percentage and on macrophage MHC-II molecule expression.
CONCLUSION: Low dose resveratrol enhanced cell-mediate immune response. Promoting Th1 cytokine production and influencing on macrophage function might be its mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370094

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  21 in total

1.  The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.

Authors:  Brenda L Soto; Jacquelyn A Hank; Tyler J Van De Voort; Lalita Subramanian; Arthur S Polans; Alexander L Rakhmilevich; Richard K Yang; Songwong Seo; KyungMann Kim; Ralph A Reisfeld; Stephen D Gillies; Paul M Sondel
Journal:  Cancer Immunol Immunother       Date:  2011-02-22       Impact factor: 6.968

2.  Resveratrol prolongs allograft survival after liver transplantation in rats.

Authors:  Sheng-Li Wu; Liang Yu; Ke-Wei Meng; Zhen-Hua Ma; Cheng-En Pan
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

3.  Enzymatic Biosynthesis of Novel Resveratrol Glucoside and Glycoside Derivatives.

Authors:  Ramesh Prasad Pandey; Prakash Parajuli; Ju Yong Shin; Jisun Lee; Seul Lee; Young-Soo Hong; Yong Il Park; Joong Su Kim; Jae Kyung Sohng
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

4.  Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.

Authors:  Brenda L Soto; Jacquelyn A Hank; Soesiawati R Darjatmoko; Arthur S Polans; Eric M Yanke; Alexander L Rakhmilevich; Songwon Seo; KyungMann Kim; Ralph A Reisfeld; Stephen D Gillies; Paul M Sondel
Journal:  Int Immunopharmacol       Date:  2011-08-18       Impact factor: 4.932

5.  Cross effects of resveratrol and mesenchymal stem cells on liver regeneration and homing in partially hepatectomized rats.

Authors:  Erdem Okay; Turgay Simsek; Cansu Subasi; Abdullah Gunes; Gokhan Duruksu; Yesim Gurbuz; Gulcin Gacar; Erdal Karaoz
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

6.  In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against Leishmania major promastigotes and amastigotes.

Authors:  Lukasz Kedzierski; Joan M Curtis; Milena Kaminska; Jadwiga Jodynis-Liebert; Marek Murias
Journal:  Parasitol Res       Date:  2007-09-01       Impact factor: 2.289

7.  Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis.

Authors:  Nabiha Yusuf; Tahseen H Nasti; Sreelatha Meleth; Craig A Elmets
Journal:  Mol Carcinog       Date:  2009-08       Impact factor: 4.784

8.  Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells.

Authors:  Yoo Jin Choi; Kwang Mo Yang; Sung Dae Kim; Young Hyun Yoo; Sang Wha Lee; Su Yeong Seo; Hongsuk Suh; Sung Tae Yee; Min Ho Jeong; Wol Soon Jo
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

9.  Sphingolipids as new biomarkers for assessment of delayed-type hypersensitivity and response to triptolide.

Authors:  Feng Qu; Cai-Sheng Wu; Jin-Feng Hou; Ying Jin; Jin-Lan Zhang
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Isogarcinol is a new immunosuppressant.

Authors:  Juren Cen; Mingshu Shi; Yanfang Yang; Yanxia Fu; Hailing Zhou; Mengqi Wang; Zhenyi Su; Qun Wei
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.